Exabis Library
Welcome to the e-CCO Library!
P296: Levels of engagement in physical activity and fatigue in IBD patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P296: MAGNIFI-CD index is appropriate for treatment monitoring in perianal Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P296: Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index score
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P296: Stopping 5-aminosalicylic acid in patients with ulcerative colitis who are in clinical remission does not increase risks of flare
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P296: vedolizumab Does Not Increase Risk of Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease Using vedolizumab: a Retrospective Cohort Study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P297 Novel serum soluble markers of histological healing in ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P297: Evaluation of the clinical course of Adolescent inflammatory bowel disease patients at Nottingham University Hospital
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P297: Fecal calprotectin accurately predicts symptomatic relapse in children and adolescents with inflammatory bowel disease in clinical remission
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P297: HLA-DQA1*05 allele and its association with the secondary loss of response to infliximab in patients with Inflammatory Bowel Disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P297: The change of bone mineral density in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P297: The Toronto IBD Global Endoscopic Reporting (TIGER) Score and its Ability to Predict Outcomes Regarding Steroid and Biologic Use in Ulcerative Colitis and Crohn's Disease Patients – A Construct Validation Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P297: Treatment of patients with complex perianal Crohn's disease with darvadstrocel: a single-institution real life experience.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P297: Ulcerative colitis and proximal extension of the disease: a sub-group with worse prognosis?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P298 Patient-reported outcomes: the ICHOM standard set for IBD in real-life practice helps quantify deficits in current care
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P298: Budesonide MMX versus Prednisolone for Ulcerative Colitis: Comparative outcomes from a British retrospective multi-centre study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P298: Comparison between clinical and patient-reported symptoms among Crohn's disease and ulcerative colitis patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P298: Comparison of the familial and sporadic cases of inflammatory bowel diseases in long-term follow-up regarding step-up treatment, clinical, and biochemical parameters
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P298: Crohn’s disease or intestinal tuberculosis: The unsolved enigma
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P298: Pregnancy in Crohn's and Colitis - Observations, Levels and Outcomes Extension (PICCOLO-X) Study: Biological therapy reduces faecal calprotectin and the need for corticosteroids in pregnant women with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P298: Risk factors for the progression of non-alcoholic fatty liver disease in people with inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM